flufenamic acid and fusidic acid

flufenamic acid has been researched along with fusidic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Allaire, N; Brickelmaier, M; Frisque, RJ; Gorelik, L; Kartikeyan, R; Lugovskoy, A; Reviriego-Mendoza, MM; Simon, K1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Blaschitz, K; Cespugli, M; Durmaz, V; Groiss, S; Gruber, CC; Gruber, K; Hetmann, M; Köchl, K; Krassnigg, A; Langner, C; Loibner, M; Ruau, D; Steinkellner, G; Zatloukal, K1

Other Studies

3 other study(ies) available for flufenamic acid and fusidic acid

ArticleYear
Identification and characterization of mefloquine efficacy against JC virus in vitro.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Antiviral Agents; Astrocytes; Cell Line, Transformed; Cells, Cultured; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Microbial Sensitivity Tests; Models, Molecular; Neuroglia; Simian virus 40; Virus Replication

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX.
    Scientific reports, 2023, 07-21, Volume: 13, Issue:1

    Topics: Acetylcholinesterase; COVID-19; Flufenamic Acid; Fusidic Acid; Humans; Papain; Peptide Hydrolases; SARS-CoV-2

2023